Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$66.9M |
| 2 |
Tesla
TSLA
|
+$17M |
| 3 |
Starbucks
SBUX
|
+$7.73M |
| 4 |
Alibaba
BABA
|
+$5.61M |
| 5 |
Ferguson
FERG
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$8.46M |
| 2 |
United Parcel Service
UPS
|
+$6.5M |
| 3 |
Medtronic
MDT
|
+$5.4M |
| 4 |
Palo Alto Networks
PANW
|
+$5.27M |
| 5 |
3M
MMM
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.5% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 11.88% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.93% |
Similar funds
Bayesian Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Bayesian Capital Management held 1,116 positions worth $684M, up 39% from $493M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bayesian Capital Management deployed $175M of net new capital in Q4 2022, opening 453 new positions and adding to 148 existing holdings. Its largest new stake was Tesla: 89,769 shares worth $11.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $5.4M trimmed.
- Bayesian Capital Management's largest Q4 2022 buy was Tesla: 89,769 shares worth $11.1M.
- Bayesian Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $66.9M increase.
- Bayesian Capital Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $5.4M.
- Bayesian Capital Management fully exited Micron Technology in Q4 2022, selling an estimated $8.46M.
- Bayesian Capital Management's ten largest holdings make up 22% of its $684M portfolio in Q4 2022.
- Bayesian Capital Management opened 453 new positions and closed 375 in Q4 2022.
- Bayesian Capital Management's portfolio value rose 39% quarter-over-quarter to $684M.
Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.